Home › Overweight › Arkansas
Overweight clinical trials in Arkansas
7 studies for Overweight are looking for participants at sites in Arkansas.
Cities in Arkansas
A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)
- Preferred Research Partners, Inc., Little Rock
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07823608A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Little Rock
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT07784270A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Little Rock
RecruitingPhase 3Healthy volunteers welcome
Ages 18 to 79 · All sexes · Updated Oct 20, 2026 · NCT07654374Continuous Glucose and E-Monitoring to Support Healthy Weight Gain in Pregnancies - The GEM Study
- Arkansas Children's Research Institute - Arkansas Children's Nutrition Center, University of Arkansas for Medical Sciences, Little Rock
Recruiting
Ages 18 to 45 · Women · Updated Oct 9, 2026 · NCT06666257A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Little Rock
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07743450A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, Little Rock
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07743463Time Restricted Feeding, Muscle, and Metabolism
- University of Arkansas, Fayetteville
RecruitingHealthy volunteers welcome
Ages 25 to 50 · All sexes · Updated Aug 26, 2025 · NCT04949451From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.